Summit Partners Public Asset Management »

Lenz Therapeutics shares owned by Summit Partners Public Asset Management

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Summit Partners Public Asset Management from 13F filings

Historical chart of Summit Partners Public Asset Management investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Summit Partners Public Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Summit Partners Public Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $15M 324k 46.58
2025-06-30 $7.0M 240k 29.31

More positions owned by Summit Partners Public Asset Management

Sandisk Corp Put Option (SNDK)
Insmed Com Par $.01 (INSM)
Mongodb Cl A Put Option (MDB)
Spotify Technology S A SHS (SPOT)
NVIDIA Corporation Call Option (NVDA)
Carvana Cl A Call Option (CVNA)
Solaris Energy Infras Com Cl A (SEI)
Ge Vernova (GEV)
Credo Technology Group Holdi Ordinary Shares Put Option (CRDO)
Tower Semiconductor Shs New (TSEM)
Ionis Pharmaceuticals Put Option (IONS)
Genedx Holdings Corp Com Cl A (WGS)
Cidara Therapeutics Com New (CDTX)
Jfrog Ord Shs (FROG)
Natera (NTRA)

View all positions for Summit Partners Public Asset Management

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
BlackRock
UBS Group
Vanguard Group
Franklin Resources
72 Investment Holdings
Tang Capital Management
Adage Capital Partners GP
Intrinsic Edge Capital Management
State Street Corporation
CAM Group Holding A/S
Squarepoint Ops
Standard Life Aberdeen

View all funds holding Lenz Therapeutics